Regulatory Interaction for CRISPR-Mediated Gene Therapy: Data Preparation and Reporting
Before transfer to a clinical environment, CRISPR-Mediated gene therapies are subject to internal and external regulatory audits. IDT can provide regulatory expertise to support you in your CRISPR-based therapy development.
Clinical expansion for patient treatment requires data reporting and analysis to ensure processes are followed and data recorded. Generate reports and concatenate data captured in IDBS Polar Biopharma Lifecycle Management software, saving time and delivering a complete data set for Pre- and Post-IND filings.